J1954 HCPCS Level II code: Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg

J1954 is the HCPCS code for “Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J1954

Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg

Short description: Inj leu acet lutr dpt 7.5 mg

HCPCS · United States

Medicare details

The indicators CMS publishes with J1954 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care
BETOS category
Chemotherapy
Added
Jan 1, 2023

Where J1954 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J1954 mean?

J1954 is the HCPCS code for “Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J1954?

CMS lists J1954’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.